• JHU-083 for Glutaminase Pathway Research

  2026-08-24

  JHU-083 provides a practical way to interrogate glutaminase activity in cerebral CD11b cells, experimental cerebral malaria research, and glutamate excitotoxicity models. This guide connects cell-resolved glutamate measurements with the redox and multi-omics workflow highlighted in a recent hepatotoxicity study, while separating validated product facts from assay-development recommendations.

• Brefeldin A Workflows for ER Stress Research

  2026-08-24

  Brefeldin A (BFA) provides a practical way to perturb ER-to-Golgi trafficking, connect secretion defects with ER stress, and examine downstream apoptosis. This workflow also shows how BFA can be used cautiously alongside moesin-centered endothelial injury assays to separate trafficking-dependent effects from sepsis-associated barrier dysfunction.

• DHEA: Mechanisms, Evidence, and Research Use

  2026-08-23

  Dehydroepiandrosterone (DHEA) is an endogenous steroid hormone and neurosteroid used to study steroid metabolism, neuroprotection, apoptosis inhibition, and ovarian biology. Product data support defined cell and animal research workflows, but the reported preclinical effects do not establish clinical efficacy.

• Cisplatin Workflows for Chemoresistance Research

  2026-08-22

  Build reproducible CDDP experiments that connect DNA crosslinking, apoptosis, oxidative stress, and drug-response heterogeneity. This guide translates a head and neck cancer study into practical cell, organoid, and xenograft workflows with handling controls and troubleshooting strategies.

• Homoharringtonine: Mechanism to Assay Design

  2026-08-22

  Homoharringtonine is a cytotoxic alkaloid whose ribosome-level activity connects leukemia research with emerging SARS-CoV-2 antiviral research. This guide focuses on translating its mechanism into rigorous, compartment-aware assay design and evidence interpretation.

• Primidone: TRPM3 and RIPK1 Research Workflows

  2026-08-21

  Primidone, also known as Mysoline, connects TRPM3 channel inhibition with RIPK1-focused neurodegeneration and pain research. This practical guide covers concentration selection, animal model dosing, assay controls, formulation, and troubleshooting for reproducible translational studies.

• EdU Imaging Kits (488): Practical Workflow

  2026-08-20

  EdU Imaging Kits (488) turn S-phase DNA synthesis into a sensitive fluorescence readout for microscopy and flow cytometry without harsh DNA denaturation. This guide shows how to apply the assay to proliferation studies, including translational evaluation of emerging glioblastoma therapies such as implantable Tumor Treating Fields.

• Z-VAD-FMK: Reframing Apoptosis and Necroptosis

  2026-08-20

  Z-VAD-FMK is more than a broad apoptosis inhibitor: it is a causal tool for separating caspase-dependent death from necroptosis. This translational framework connects inhibitor selection, lysosomal membrane permeabilization, MLKL polymerization, and reproducible pathway validation.

• Topotecan: Pharmacology, Mechanism, and Clinical Evidence

  2026-08-19

  The 1999 review by Kollmannsberger and colleagues presents topotecan as a water-soluble camptothecin derivative that stabilizes DNA–topoisomerase I cleavable complexes and produces replication-associated DNA damage. Its synthesis of pharmacokinetic, toxicity, scheduling, and early clinical data explains both the drug’s activity in ovarian and small-cell lung cancers and the unresolved questions surrounding renal dosing and combination therapy.

• Ionisable Lipid and Sterol Effects in LNPs

  2026-08-19

  The 2025 Journal of Controlled Release study systematically compares proprietary ionisable lipids with ALC-0315 to show how lipid structure influences LNP physicochemical properties, mRNA expression, and tissue distribution. Its main practical implication is that in vitro performance cannot substitute for route-specific in vivo evaluation, while ionisable lipid chemistry generally has a stronger influence on mRNA delivery than sterol selection.

• U-73122: Phospholipase C Inhibitor Guide

  2026-08-18

  U-73122 is a phospholipase C inhibitor used to interrogate PLC signaling pathway modulation, calcium flux, chemotaxis, inflammation, and cancer-cell invasion. Product data report approximately micromolar cellular activity, while a breast cancer study links U73122 treatment with reversal of QPRT-associated invasion and myosin light-chain phosphorylation.

• Dextran sulfate sodium salt in DSS Colitis Models

  2026-08-18

  Learn how Dextran sulfate sodium salt (MW 35000-45000) creates a controlled intestinal injury platform for epithelial-barrier research, therapeutic screening, and repair biology. The workflow connects DSS-induced damage with the GPR35-KLF5 repair circuit while emphasizing dose control, recovery-phase sampling, and troubleshooting.

• Forsythoside E: A PKM2 Assay Design Guide

  2026-08-17

  Forsythoside E is a mechanistically distinctive pyruvate kinase M2 (PKM2) inhibitor for studying macrophage immunometabolism. This guide connects target engagement, glycolytic remodeling, STAT3 signaling, and assay design while defining the limits of current sepsis-liver injury evidence.

• Forsythoside E: PKM2 Workflow Guide

  2026-08-17

  Forsythoside E connects PKM2 tetramerization with macrophage metabolism, STAT3 signaling, and sepsis-induced liver injury research. This practical guide translates its binding and dosing data into assay design, formulation control, and troubleshooting decisions.

• EdU Imaging Kits (488) for Tumor Cell-Cycle Studies

  2026-08-16

  EdU Imaging Kits (488) translate DNA-replication activity into a sensitive, imageable readout for cancer and cell-cycle experiments. This guide shows how to pair 5-ethynyl-2'-deoxyuridine labeling with microscopy or flow cytometry when evaluating emerging therapies such as implantable Tumor Treating Fields.

8514 records 4/568 page Previous Next 12345 下5页 Last page